Hemoglobin A1 Test

If you carry a gene for sickle cell trait, thalassemia, or another inherited hemoglobin condition, your body quietly produces less of the normal adult hemoglobin and more of an abnormal or compensatory type. A standard complete blood count (CBC) can tell you that something looks off with your red blood cells, but it cannot tell you why. Hemoglobin A1 answers that question.

This measurement, performed as part of a hemoglobin electrophoresis (a lab technique that separates hemoglobin into its individual types), tells you what percentage of your hemoglobin is the normal adult form. When that percentage is lower than expected, the remaining hemoglobin is made up of variant forms that point directly to specific genetic conditions.

What Hemoglobin A1 Is

Hemoglobin is the oxygen-carrying protein packed inside every red blood cell. Your body can produce several types, but in a healthy adult, the vast majority is Hemoglobin A1 (sometimes written as HbA). This version is built from two alpha globin chains and two beta globin chains, folded together around an iron-containing core that grabs oxygen in your lungs and releases it to your tissues.

A small fraction of your hemoglobin is Hemoglobin A2 (a minor adult form using delta chains instead of beta chains), and an even smaller fraction is Hemoglobin F (the fetal form). When these minor types make up a larger share than normal, it usually means the genes responsible for building normal beta chains are not working correctly.

Inherited Blood Disorders

The primary reason to measure Hemoglobin A1 is to screen for or confirm inherited conditions called hemoglobinopathies, which are genetic disorders that alter the structure or production of hemoglobin chains. The most common include sickle cell disease and its carrier state (sickle cell trait), beta-thalassemia trait and disease, and Hemoglobin C disease.

In beta-thalassemia trait, for example, one of the two beta-globin genes is faulty, so the body produces less normal Hemoglobin A1 and compensates by making more Hemoglobin A2 and sometimes more Hemoglobin F. In sickle cell trait, one gene codes for the abnormal Hemoglobin S instead of normal beta chains, which means Hemoglobin A1 drops to roughly 55 to 60 percent of total hemoglobin while Hemoglobin S fills the gap.

A person with sickle cell disease (two copies of the sickle gene) may have little to no Hemoglobin A1 at all, with Hemoglobin S dominating the result. Seeing these proportions on a hemoglobin electrophoresis report is what confirms the diagnosis.

Carrier Screening and Family Planning

Many people carry a single copy of an abnormal hemoglobin gene without ever knowing it. Sickle cell trait and beta-thalassemia trait often cause no symptoms or only mild anemia that gets overlooked on routine labs. But if two carriers have children together, each pregnancy carries a one-in-four chance of producing a child with the full disease.

Knowing your Hemoglobin A1 proportion, along with the presence or absence of variant hemoglobins, gives you and your partner the information needed to assess genetic risk before conception. This is one of the most actionable uses of the test for otherwise healthy adults.

Anemia That Does Not Respond to Iron

If you have been told you are mildly anemic with small red blood cells (low MCV, or mean corpuscular volume), and iron supplements have not fixed the problem, thalassemia trait is a common explanation. Your Hemoglobin A1 will be mildly reduced and your Hemoglobin A2 will be elevated. Without electrophoresis, this pattern is invisible, and you may spend months or years taking iron you do not need.

Reference Ranges

The following ranges represent widely accepted clinical values for adults measured by standard hemoglobin electrophoresis. Your lab may report slightly different cutpoints depending on the method used.

Compare your results within the same lab over time. If you have already been diagnosed with a hemoglobinopathy, the proportions should be stable across tests. A shift in proportions can signal a new condition, a transfusion effect, or a lab processing issue.

When Results Can Be Misleading

A recent blood transfusion introduces donor hemoglobin into your sample, which can temporarily normalize your Hemoglobin A1 percentage and mask an underlying variant. If you have received a transfusion in the past three months, let your provider know before interpreting the result.

Severe iron deficiency can lower Hemoglobin A2 into the normal range, potentially hiding beta-thalassemia trait. If iron deficiency is suspected, it should be corrected before repeating hemoglobin electrophoresis to get an accurate A1 and A2 reading.

Certain lab methods may not clearly separate all hemoglobin variants. If a result is ambiguous, confirmatory testing using a different technique (such as high-performance liquid chromatography, or HPLC) or genetic testing may be recommended.

Tracking Your Result Over Time

For most people, Hemoglobin A1 is genetically determined and stable throughout life. A single measurement is usually enough to establish your hemoglobin pattern. Unlike biomarkers that fluctuate with diet or lifestyle, your hemoglobin type does not change from month to month.

That said, there are situations where retesting matters. If your initial test was drawn during acute illness, after a transfusion, or while you were severely iron-deficient, a repeat test under normal conditions confirms the true result. For people with known hemoglobinopathies who develop new symptoms or worsening anemia, a repeat electrophoresis can help rule out additional conditions or complications.